Reply to: "Model for end-stage liver disease-sodium in acute-on-chronic liver failure"
- PMID: 32988657
- DOI: 10.1016/j.jhep.2020.08.004
Reply to: "Model for end-stage liver disease-sodium in acute-on-chronic liver failure"
Keywords: Cirrhosis; Natural history; Outcomes; Prognosis; Transplant center.
Conflict of interest statement
Conflict of interest The authors declare no conflicts of interest that pertain to this work. Please refer to the accompanying ICMJE disclosure forms for further details.
Comment on
-
Model for end-stage liver disease-sodium underestimates 90-day mortality risk in patients with acute-on-chronic liver failure.J Hepatol. 2020 Dec;73(6):1425-1433. doi: 10.1016/j.jhep.2020.06.005. Epub 2020 Jun 10. J Hepatol. 2020. PMID: 32531416 Free PMC article.
-
Model for end-stage liver disease-sodium in acute-on-chronic liver failure.J Hepatol. 2020 Dec;73(6):1578-1579. doi: 10.1016/j.jhep.2020.07.022. Epub 2020 Sep 12. J Hepatol. 2020. PMID: 32933782 No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
